Skip to main content
Iterum Therapeutics plc logo

Iterum Therapeutics plc — Investor Relations & Filings

Ticker · ITRM ISIN · IE000TTOOBX0 US Manufacturing
Open in API
Filings indexed 506 across all filing types
Latest filing 2018-05-29 Director's Dealing
Country US United States of America
Listing US ITRM

About Iterum Therapeutics plc

https://www.iterumtx.com/

Iterum Therapeutics plc is a pharmaceutical company focused on developing and commercializing differentiated anti-infectives to combat multi-drug resistant (MDR) pathogens. The company's lead product is sulopenem, a novel penem anti-infective compound developed in both oral and intravenous (IV) formulations. The oral formulation, ORLYNVAH™, has received U.S. FDA approval for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women caused by designated susceptible microorganisms. ORLYNVAH™ is the first oral penem antibiotic approved in the United States, addressing the need for new treatment options against the growing threat of antibiotic-resistant bacteria.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2018-05-29 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the U.S. Securities and Exchange Commission. It pertains to the registration of securities under the Securities Act of 1933, specifically related to equity incentive plans. The document includes detailed information about the securities to be registered, calculation of registration fees, incorporation by reference of other filings, and exhibits related to equity incentive plans. This type of filing is a registration statement for securities offerings, not a financial report, earnings release, or management discussion. It is not an announcement or a proxy statement but a formal registration document for securities issuance under employee benefit plans. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2018-05-25 English
424B4
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for an initial public offering (IPO) of ordinary shares, including extensive information about the company's business, management, financial data, risk factors, and use of proceeds. It is filed pursuant to Rule 424(b)(4), which is a prospectus filing related to securities offerings. This type of document is a capital markets offering document, not a financial report, earnings release, or management discussion. It provides detailed information for investors about the offering and the company but does not fit into categories like Annual Report, Earnings Release, or Management Reports. The appropriate classification for such a document is Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPO prospectuses.
2018-05-25 English
Regulatory Filings 2018
Regulatory Filings
2018-05-25 English
POST-EFFECTIVE AMENDMENT #1 TO FORM S-1
Regulatory Filings Classification · 100% confidence The document is titled 'Post-Effective Amendment No. 1 to Form S-1 Registration Statement' filed with the SEC. It references the Securities Act of 1933 and is a post-effective amendment to a registration statement, specifically Form S-1. The content includes exhibits, agreements, consents, and signatures related to the registration statement. There is no financial performance data or quarterly/yearly financial results presented. The document is a regulatory filing related to securities registration and amendments, not a financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length is 9802 characters, which is substantial but the content is clearly a regulatory filing amendment rather than a financial report or announcement of a report.
2018-05-25 English
FORM 3 SUBMISSION
Director's Dealing
2018-05-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.